Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment
Authors:
Open Access
- 15 September 2011
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 124 (18) , 3084-3094
Abstract
Brain tumors frequently recur or progress as focal masses after treatment with ionizing radiation. However, the mechanisms underlying the repopulation of tumor cells after radiation have remained unclear. In this study, we show that cellular signaling from Abelson murine leukemia viral oncogene homolog (Abl) to protein kinase Cδ (PKCδ) is crucial for fractionated-radiation-induced expansion of glioma-initiating cell populations and acquisition of resistance to anticancer treatments. Treatment of human glioma cells with fractionated radiation increased Abl and PKCδ activity, expanded the CD133-positive (CD133+) cell population that possesses tumor-initiating potential and induced expression of glioma stem cell markers and self-renewal-related proteins. Moreover, cells treated with fractionated radiation were resistant to anticancer treatments. Small interfering RNA (siRNA)-mediated knockdown of PKCδ expression blocked fractionated-radiation-induced CD133+ cell expansion and suppressed expression of glioma stem cell markers and self-renewal-related proteins. It also suppressed resistance of glioma cells to anticancer treatments. Similarly, knockdown of Abl led to a decrease in CD133+ cell populations and restored chemotherapeutic sensitivity. It also attenuated fractionated-radiation-induced PKCδ activation, suggesting that Abl acts upstream of PKCδ. Collectively, these data indicate that fractionated radiation induces an increase in the glioma-initiating cell population, decreases cellular sensitivity to cancer treatment and implicates activation of Abl–PKCδ signaling in both events. These findings provide insights that might prove pivotal in the context of ionising-radiation-based therapeutic interventions for brain tumors.Keywords
This publication has 39 references indexed in Scilit:
- Potential therapeutic implications of cancer stem cells in glioblastomaBiochemical Pharmacology, 2010
- Selective targeting of radiation-resistant tumor-initiating cellsProceedings of the National Academy of Sciences, 2010
- The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cellsRadiation Oncology, 2009
- Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90Molecular Cancer Therapeutics, 2009
- The Increasing Complexity of the Cancer Stem Cell ParadigmScience, 2009
- Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src‐transformed cellsJournal of Cellular Physiology, 2009
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell SurvivalCancer Cell, 2009
- EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenograftsInternational Journal of Cancer, 2008
- CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesCancer Research, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006